InsidersTradesSigma
세니젠 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 세니젠 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 세니젠 has recorded 27 public disclosures. Market capitalisation: €25.5bn. The latest transaction was reported on 10 July 2026 (Purchase). Among the most active insiders: 박정웅. Every trade is openly available.
26
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
10 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,156 of 27,849 companies
11.0
score / 100
Value11
Quality11
FCF yld-17%
Earn yld-23%
EV/EBITDA·
ROE-94%
Gross mgn20%
Net mgn-38%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 July 2026
Declarations27 total
Other
Other(filed)
25 of 27 declarations
About 세니젠
세니젠 is a healthcare and pharmaceutical company listed on the XKRX. It specializes in developing innovative solutions for disease treatment.